Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodies

Blood

Volumn 87, Issue 9, 1996, Pages 3640-3649

  White, Christine A ^a   Halpern, Samuel E ^b   Parker, Barbara A ^b   Miller, Richard A ^b   Hupf, Homer B ^b   Shawler, Daniel L ^b   Collins, Heli A ^b   Royston, Ivor ^b  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; YTTRIUM 90;

ADULT; AGED; ARTHRALGIA; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; HYPOTENSION; ISOTOPE LABELING; LIVER TOXICITY; MALE; NEUROPATHY; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RELAPSE; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; RADIOIMMUNOTHERAPY; RECURRENCE; YTTRIUM RADIOISOTOPES;

EID: 0029922166     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3640.bloodjournal8793640     Document Type: Article

References (34)

1. Nadler LM, Stashenko P, Hardy R, Kaplan WD, Button LN, Kufe DW, Antman KH, Schlossman SF: Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res 40:3147, 1980
2. Press OW, Applebaum F, Ledbetter JA, Martin P, Zarling J, Kidd P, Thomas EE: Monoclonal antibody IF5 (anti-CD20) serotherapy of human B-cell lymphomas. Blood 69:584, 1987
3. Hale G, Dyer MJ, Clark MR, Phillips JM, Marcus R, Reichmann L, Winter G, Waldmann H: Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAM-PATH-1H. Lancet 2:1394, 1988
4. Ritz J, Pesando JM, Sallan SE, Clavell LA, Notis-McConarty J, Rosenthal P, Schlossman SF: Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 58:141, 1981
5. Dillman RO, Shawler DL, Sobol RE, Collins HA, Beauregard JC, Wormsley SB, Royston I: Marine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia. Blood 59:1036, 1982
6. Miller RA, Maloney DG, Warnke R, Levy R: Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Eng J Med 306:516, 1982
7. Thieleman K, Maloney DG, Meeker T, Fujimoto J, Doss C, Warnke R, Bindl J, Gralow J, Miller RA, Levy R: Strategies for production of monoclonal anti-idiotype antibodies against human B-cell lymphomas. J Immunol 133:495, 1984
8. Meeker TC, Lowder JN, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R: A clinical trial of anti-idiotype therapy for B-cell malignancy. Blood 65:1349, 1985
9. Meeker TC, Lowder JN, Clearly ML, Stewart S, Warnke R, Sklar J, Levy R: Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med 312.1658, 1985
10. Clearly ML, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Levy R: Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B-cell lymphoma. Cell 44:97, 1986
11. Maloney DG, Brown S, Czerwinski DK, Liles TM, Hart SM, Miller RA, Levy R: Monoclonal anti-idiotype therapy of B-ceil lymphoma: The addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells. Blood 80:1502, 1992
12. Brown S, Miller R, Horning S, Czerwinski D, Hart SM, McEldererry, Basham T, Warnke RA, Merigan TC, Levy R: Treatment of B-cell lymphoma with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73:651, 1989
13. Halpern SE, Dillman RO: Probléms associated with radioimmunodetection and possibilities for future solutions. J Biol Response Mod 6:235, 1987
14. 131I Lym-1 monoclonal antibody. Antibody Immunoconj Radiopharm 1:17, 1988
15. Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp WB, Krohn KA, Fisher D, DeSantes K, Porter B, Kidd P, Thomas D, Bernstein ID: Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 7:1027, 1989
16. 131-labeled LL-2 monoclonal antibody. J Clin Oncol 9:548, 1991
17. Stern P, Hagan P, Halpern S, Chen A, David G, Adams T, Desmond W, Brautigam K, Royston I: The effect of the radiolabel on the kinetics of monoclonal anti-CEA in nude mouse human tumor model, in Mitchell MS, Oettgen HF (eds): Hybridomas in Cancer Diagnosis and Treatment. New York, NY, Raven, 1982, p 245
18. Miller RA, Hart S, Samoszuk M, Coulter C, Brown S, Czerwinski D, Kelkenberg J, Royston I, Levy R: Shared idiotypes expressed by human B-cell lymphomas. N Engl J Med 321:851, 1989
19. Evans TL, Miller RA: Large scale production of murine monoclonal antibody using hollow fiber bioreactors. Biotechniques 6:762, 1988
20. 90Y-conjugated anti-idiotype monoclonal antibody. Cancer Res 50:1022, 1990 (suppl)
21. 90Y antiferritin - A new therapeutic radiolabeled antibody. Int J Radiat Oncol Biol Phys 12:277, 1986
22. Vriesendorp HM, Order SE: Hodgkin's disease. New possibilities for clinical research. Int J Radiat Oncol Biol Phys 17:1119, 1989
23. Shawler DL, McCallister TJ, Sobol RE, Dillman RO: Serologic and cellular assays to monitor therapy with murine monoclonal antibodies. J Clin Lab Anal 1:184, 1987
24. Sobol RE, Mick R, Royston I, Davy FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield CD: Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316:1111, 1987
25. Martin KW, Halpern SE: Carcinoembryonic antigen production, secretion, and kinetics in Balb/c mice and a nude mouse-human tumor model. Cancer Res 44:5475, 1984
26. 90Y-anti-idiotype monoclonal antibody, in Borrebaeck CAK, Larnick JW (eds): Therapeutic monoclonal antibodies. New York, NY, Stockton, 1990, p 127
27. Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R: Studies on B-lymphoid rumors treated with monoclonal anti-idiotype antibodies: Correlation with clinical responses. Blood 69:199, 1987
28. 111In-labeled monoclonal antitumor antibodies: Kinetics, biodistribution, and tumor detection. Radiology 168:529, 1988
29. 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse models. Cancer Res 43:5347, 1983
30. Halpern SE, Dillman RO, Witytum KF, Shega JF, Hagan PL, Burrows WM, Dilman JB, Clutter ML, Sobol RE, Frinche JM, Bartholomew RM, David GS, Carlo DJ: Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: A preliminary report. Radiology 155:493, 1985
31. Hagen PL, Halpern SE, Dillman RO, Shawler DL, Johnson DE, Chen A, Krishnan L: Tumor size: Effect on monoclonal antibody uptake in tumor models. J Nucl Med 27:422, 1986
32. Cataland S, Cohen C, Sapirstein LA: Relationship between size and perfusion rate of transplanted tumors. J Natl Cancer Inst 29:389, 1962
33. Vaupel P: Hypoxia in neoplastic tissue. Microvasc Res 13:399, 1977
34. 131I]anti-B (anti-CD20) antibody. N Engl J Med 329:459, 1993